June 30, 2022

Volume XII, Number 181

Advertisement
Advertisement

June 29, 2022

Subscribe to Latest Legal News and Analysis

June 28, 2022

Subscribe to Latest Legal News and Analysis

June 27, 2022

Subscribe to Latest Legal News and Analysis

Congress Edges Toward Regulation of Cannabis

This week, a bipartisan group of House members moved forward with a proposal to federally regulate cannabis similarly to the regulation of alcohol.  Written by Reps. Dave Joyce, R-OH, Hakeem Jeffries, D-NY, and Brian Mast, R-FL, the PREPARE Act would establish a federal commission to advise Congress on the most effective means of regulating cannabis.

This particular bill would not legalize cannabis. Instead, within a year of passage, the Commission would be required to provide a report to Congress suggesting a system to develop safety standards for the manufacture and sale of cannabis products, with enforcement authority shared with the states.  The commission would also be required to generate new policies aimed at repairing damage to low-income, veteran and minority communities, which the proponents of the legislation believe have been disproportionately impacted by cannabis prohibition, as well as easing medical researchers’ access to cannabis.  The prospects for passage of the Act are unclear. However,  the Act appears to be receiving serious consideration, which suggests a movement toward regulation as opposed to prohibition of cannabis.

In a parallel move in the Senate, New York Senator Chuck Schumer has introduced the Cannabis Administration & Opportunity Act (CAOA).  The CAOA would end federal prohibition and criminalization of cannabis.  Senator Schumer aims to remove cannabis from the federal list of controlled substances.

It is unclear how these proposals may impact the regulation of cannabidiols (CBD).

© 2022 Keller and Heckman LLPNational Law Review, Volume XII, Number 105
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

Keller and Heckman offers global food and drug services to its clients. Our comprehensive and extensive food and drug practice is one of the largest in the world. We promote, protect, and defend products made by the spectrum of industries regulated by the U.S. Food and Drug Administration (FDA), the European Commission and Member States authorities in the European Union (EU) and similar authorities throughout the world. The products we help get to market include foods, pharmaceuticals, medical devices, veterinary products, dietary supplements, and cosmetics. In addition...

202-434-4100
Advertisement
Advertisement
Advertisement